AUAUniversity offentlig
[search 0]
Flere
Download appen!
show episodes
 
Loading …
show series
 
AUA2024: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice ProviderCME Available: https://auau.auanet.org/node/41048At the conclusion of this activity, participants will be able to:1. Define the similarities and differences between the various oral pharmacotherapies for overactive bladder (OAB)2. Review the principles of physio…
  continue reading
 
Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder (OAB) Webcast (2024)CME Available: https://auau.auanet.org/node/41056At the conclusion of this activity, participants will be able to:1. Discuss the third-line therapies available to treat OAB refractory to conservative techniques.2. Effectively provide counseling re…
  continue reading
 
AUA2024: 003IC Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical PracticeCME Available: https://auau.auanet.org/node/40976At the conclusion of this activity, participants will be able to:1. Describe key components of genetic risk assessment, genetic counseling and informed consent for genet…
  continue reading
 
AUA2024: Surgical Laser Enucleation of the ProstateGuests: Amy Krambeck, MD and Mark Assmus, MDOutline:Segment #1: Why EnucleationSegment #2: What makes this course special?Segment #3: What is new this year compared to last year?Segment #4: What do you think makes this course unique?Segment #5: Who is the ideal participant?…
  continue reading
 
AUA2024: A Specialized Masterclass for Single-port Robot-Assisted SurgeryGuests: Simone Crivellaro, MD and Ahmed Ghazi MD, MHPEOutline:Segment #1 Topic: The need for ongoing surgical education given the rise in introduction of new technologies in urology.Segment #2 Topic: Current status of Hands-on skills courses in UrologySegment #3 Topic: History…
  continue reading
 
Update Series (2024) Lesson 1: A Case-Based Discussion of Priapism GuidelinesNow in its 43rd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional…
  continue reading
 
AUA2023 Take Home Messages Part 5Take Home Messages: Take Home Messages: BPH/LUTSSpeaker: Dr. Dean EltermanTake Home Messages: ImagingSpeaker: Dr. Richard MatulewiczTake Home Messages: Robotic SurgerySpeaker: Dr. Andrew HungTake Home Messages: Surgical EducationSpeaker: Dr. Simone ThavaseelanAf American Urological Association
  continue reading
 
AUA2023 Take Home Messages Part 3Take Home Messages: Infertility/AndrologySpeaker: Dr. Joshua HalpernTake Home Messages: Sexual DysfunctionSpeaker: Dr. Peter TsambarlisTake Home Messages: PediatricsSpeaker: Dr. Kate KraftTake Home Messages: Global Health/HumanitarianSpeaker: Dr. Rajiv SingalAf American Urological Association
  continue reading
 
AUA2023 Take Home Messages Part 2Take Home Messages: Basic Science (Benign)Speaker: Dr. Douglas StrandTake Home Messages: ReconstructionSpeaker: Dr. Jessica DeLongTake Home Messages: Endourology/StonesSpeaker: Dr. Noah CanvasserTake Home Messages: Infection/InflammationSpeaker: Dr. Chris DoironAf American Urological Association
  continue reading
 
AUA2023 Take Home Messages Part 1Take Home Messages: Basic Science (Malignant)Speaker: Dr. Douglas ScherrTake Home Messages: Kidney CancerSpeaker: Dr. Amy LuckenbaughTake Home Messages: Bladder CancerSpeaker: Dr. Jennifer TaylorTake Home Messages: Prostate CancerSpeaker: Dr. Samuel WashingtonAf American Urological Association
  continue reading
 
PARPi: Management of Adverse Events (2024)CME Available: https://auau.auanet.org/node/39609Release Date: January, 2024Expiration Date: January, 2025LEARNING OBJECTIVES:1. Identify approved PARPi for prostate cancer and patients who may benefit from PARPi based therapy.2. Evaluate available clinical safety and efficacy data for PARPi.3. Describe ind…
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer CME Available: https://auau.auanet.org/node/39542Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, participants will be able to:1. Identify the rationale be…
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:The Latest Breakthroughs in Immunotherapy for GU CancersCME Available: https://auau.auanet.org/node/39543Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, participants will be able to:1. Identify the newest immunothera…
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer CME Available: auau.auanet.org/node/39487Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Identify…
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Novel Imaging for Genitourinary Cancers - Diagnostics and TheranosticsCME Available: https://auau.auanet.org/node/39411Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Review the latest …
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)CME Available: https://auau.auanet.org/node/39410Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Discuss the potential benefi…
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer CME Available: https://auau.auanet.org/node/39374Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, participants will be able to:1. D…
  continue reading
 
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test (2023)CME Available: https://auau.auanet.org/node/39603Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVES:At the conclusion of this activity, the learner will be able to:1. Review recommended criteria for genetic testing of prostate cancer patients…
  continue reading
 
Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care CostsCME Available: https://auau.auanet.org/node/39485Release Date: December, 2023Expiration Date: December, 2024LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:1. Describe health care costs associated …
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Germline Testing in GU Cancers – How I Do It CME Available: https://auau.auanet.org/node/39544Release Date: December, 2023Expiration Date: December, 2024ACKNOWLEDGEMENTS:Support provided by independent educational grants from: AstraZenecaJanssen Biotech, Inc., administered by Jansse…
  continue reading
 
The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer:Treatment Intensification for Advanced Prostate CancerCME Available: https://auau.auanet.org/node/39486Release Date: November, 2023Expiration Date: November, 2024LEARNING OBJECTIVES:At the conclusion of these activities, participants will be able to:1. Identify the latest developmen…
  continue reading
 
PARPi: Precision Medicine in Advanced Prostate Cancer (2023)CME Available: https://auau.auanet.org/node/39597Release Date: November, 2023Expiration Date: November, 2024At the conclusion of this activity, the learner will be able to:1. Describe the mechanism of action of PARP inhibitors and the differences among drugs in this class.2. Describe the r…
  continue reading
 
Update Series (2023) Lesson 33: A Critical Appraisal of the 2021 AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract DysfunctionNow in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in u…
  continue reading
 
Disparities in Care and Barriers to Access for Patients with Advanced Prostate CancerCME Available: https://auau.auanet.org/node/39088Release Date: October, 2023Expiration Date: October, 2024At the conclusion of these activities, participants will be able to:1. Recognize current patterns of use for systemic therapies in patients with advanced prost…
  continue reading
 
Systemic Therapies for Advanced Prostate Cancer – Short and Long-Term Side EffectsCME Available: https://auau.auanet.org/node/39087Release Date: October, 2023Expiration Date: October, 2024At the conclusion of these activities, participants will be able to:1. Characterize current treatment paradigm for systemic therapies in managing advanced prostat…
  continue reading
 
Genetic Testing and Stone DiseaseCo-host: Kyle Wood, MDPopulation analysis demonstrated that genetic conditions resulting in stone disease are magnitudes higher than those seen in clinical cohorts, suggesting underdiagnosis. Urologist play a unique role as we often times have many touch points with these patient given their presentation for stone d…
  continue reading
 
Advances in ADT Part II: A Guide for UrologistsCME Available: https://auau.auanet.org/node/39385Release Date: October, 2023Expiration Date: October, 2024LEARNING OBJECTIVESAfter participating in this educational activity, participants will be able to:1. Recognize and characterize different disease states for advance prostate cancer including M0 HSP…
  continue reading
 
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into PracticeCME Available: https://auau.auanet.org/node/39292Release Date: September, 2023Expiration Date: September, 2024After participating in this educational activity, participants will be able to:1. Cite recommendations within the newly amended AUA/SUO Advanced Prostate Cancer Gu…
  continue reading
 
AUA2023: Managing Toxicities of Checkpoint Inhibitors: A Urologist’s GuideCME Available: https://auau.auanet.org/node/38322CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerck & Co., Inc.P…
  continue reading
 
AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent CME Available: https://auau.auanet.org/node/38312CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scient…
  continue reading
 
Treatment for Hormone Sensitive Prostate CancerCME Available: https://auau.auanet.org/node/38703Treatment for Hormone Sensitive Prostate Cancer (2023), is an exciting new educational offering to update urologists on the latest advancements in the management of hormone sensitive prostate cancer (HSPC), including treatment intensification. This educa…
  continue reading
 
Update Series (2023) Lesson 21: Management of Chronic Pelvic Pain in MenNow in its 42nd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and …
  continue reading
 
AUA2023: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice ProviderCME Available: https://auau.auanet.org/node/38307CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerc…
  continue reading
 
AUA2023: Upper-Tract Urothelial Cancer Guidelines: An Interactive and Evidence-based Course Highlighting the Full Spectrum of Disease via Case Discussion and Video PresentationCME Available: https://auau.auanet.org/node/38327CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstraZenecaMerck & Co., Inc.P…
  continue reading
 
AUA2023: What the General Urologist Should Know about Care of Transgender PatientsCME Available: https://auau.auanet.org/node/38342CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCMerck & Co., Inc.…
  continue reading
 
AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize OutcomesCME Available: https://auau.auanet.org/node/38287CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasUrovant Sciences, Inc.Af American Urological Association
  continue reading
 
AUA2023: Prostate Cancer DiagnosisCME Available: https://auau.auanet.org/node/38302CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerck & Co., Inc.Pfizer, Inc.…
  continue reading
 
Based on the findings from the 2022 AUA global survey and needs assessment in bladder cancer, the AUA has developed this new series of virtual courses to update urologists on the latest advancements in bladder cancer care. This course will address new and emerging treatment options for non‐muscle invasive (NMIBC) and muscle‐invasive bladder cancer …
  continue reading
 
AUA2023: Advancing Gender Equity in Urology: Allyship for Men and Advocacy for WomenCME Available: https://auau.auanet.org/node/38337/CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCMerck & Co., Inc.…
  continue reading
 
AUA2023: Genetics and Genomics of GU Malignancies: Applications into Your Clinical PracticeCME Available: https://auau.auanet.org/node/38317CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingM…
  continue reading
 
AUA2023: AUA Guidelines on Advanced Prostate CancerCME Available: https://auau.auanet.org/node/38297CME Expiration Date: May, 2024ACKNOWLEDGEMENTSIndependent educational grant support provided by:AstellasAstraZenecaJanssen Biotech, Inc., administered by Janssen Scientific Affairs, LLCLantheus Medical ImagingMerck & Co., Inc.Pfizer, Inc.…
  continue reading
 
Loading …

Hurtig referencevejledning